R&D The role of the opioid pathway in schizophrenia and bipolar ... Psychiatry has spent decades focused on dopamine, serotonin, norepinephrine, and glutamate.
Digital Digital mental health technologies and the changing face of ... Digital Mental Health Technologies, from apps and online platforms to AI-powered tools, are fast being seen as essential to help close treatment gaps.
News Wellcome donates £2m to UK's digital mental health drive Wellcome has provided £2m in additional funding to the MHRA and NICE for a project to build the use of digital mental health technologies in the NHS.
News UK funds 17 projects on World Mental Health Day With a record number of young people seeking mental health support in the UK, NIHR has awarded £1.5m for digital projects aiming to improve access.
Patients Purposeful prescribing in bipolar I disorder care Purposeful prescribing is the idea of making thoughtful, patient-centred decisions about medication.
News Swedish digital therapy firm Mindler buys UK rival Two players in the digital mental health space – Sweden's Mindler and ieso Digital Health UK – are joining forces through a takeover deal.
News Agios mulls early FDA filing for sickle cell therapy Agios is planning to file its sickle cell disease candidate mitapivat with the FDA under the accelerated pathway within the next few months.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
